Saliva Diagnostics (SALV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Rozenblit who wrote (2058)	2/9/1998 12:57:00 AM
From: rl	Read Replies (1) of 3369

Bruce, I am just as frightened as you about delisting. I have a substantial position in SALV. Not only will delisting cause the stock price to fall even lower (I don't know what the basement will or can be - .01?), but also it makes the stock harder to trade, although it still can be done. But when I run the possibilities through my brain, it makes very little sense to have my stock decreased 10 times, then for it to be below $1.00 again in just a short period. Without any dramatic news and with private placement participant selling, this will surely be the case. I don't believe it is any harder to get back on NASDAQ then it is to stay listed. If SALV somehow gets the stock price above $1.00 for 10 days in a row and they meet the cash and equity requirements, they can be relisted. The liquidity would dry up if the stock stayed low and private placements eat up the 50 million shares now authorized. They wouldn't have any more shares to print, but would probably come back to us to authorize more rather than go out of business. I have written before that I believe the real threat is in the Preferred Shares (these are not in the reverse) which will give a priority to buyers of those shares. You & I won't have a chance to buy them. I'm sure that they will be kept set aside for insiders. These preferred shares are as indicative of manipulation as the freshly minted management options of a company displaying record low stock value. How do we keep from killing this baby? We somehow make management more accountable and accessible. I think that a class action shareholder suit may get some response. I might also suggest running a new slate at the next SALV AGM. I challenge any of you to speak directly to the CEO. He may be at the office of SALV during the week of the proxy, but I wouldn't think before. Maybe you can get him then. rl

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next